Nicolas Villain Selected Research

Nicolas Villain Research Topics

10	Alzheimer Disease (Alzheimer's Disease) 02/2024 - 06/2008
4	Atrophy 02/2024 - 06/2008
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 04/2019
3	Parkinson Disease (Parkinson's Disease) 12/2021 - 06/2021
2	Disease Progression 01/2024 - 07/2012
2	Cognitive Dysfunction 01/2013 - 07/2012
1	Tauopathies 01/2024
1	Dementia (Dementias) 01/2023
1	Genetic Risk Score 05/2022
1	Neuroinflammatory Diseases 01/2022
1	Amyloid Plaque 01/2022
1	Brain Diseases (Brain Disorder) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2014
1	Cardiac Arrhythmias (Arrythmia) 02/2014
1	Trigeminal Neuralgia (Tic Douloureux) 02/2011
1	Pain (Aches) 02/2011

6	Biomarkers (Surrogate Marker)IBA 02/2024 - 04/2019
6	Amyloid (Amyloid Fibrils)IBA 01/2023 - 07/2012
3	aducanumabIBA 01/2023 - 11/2021
2	lecanemabIBA 01/2023 - 01/2022
2	Glucose (Dextrose)FDA LinkGeneric 11/2010 - 06/2008
1	TubulinIBA 01/2024
1	AntibodiesIBA 01/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023
1	Peptides (Polypeptides)IBA 05/2022
1	Apolipoproteins E (ApoE)IBA 05/2022
1	donanemabIBA 01/2022
1	masitinibIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 12/2021
1	Dopamine (Intropin)FDA LinkGeneric 11/2021
1	IronIBA 11/2021
1	neuromelaninIBA 11/2021
1	Apomorphine FDA Link 06/2021
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 07/2012
1	trans-crotonin (CTN)IBA 02/2011
1	Deoxyglucose (2 Deoxy D glucose)IBA 06/2008